Clinical Trial Update: Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports results for a hypofractionated boost before chemoradiation in patients with stage II–III non-small cell lung cancer u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Stage Iia Non-small Cell Lung Cancer
• Stage Iib Non-small Cell Lung Cancer
• Stage Iiia Non-small Cell Lung Cancer
• Stage Iiib Non-small Cell Lung Cancer

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Recurrent Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-06-12